Combining a classic monoamine oxidase inhibitor with a tricyclic antidepressant in therapy-resistant depression: a case report and literature review

Combining a monoamine oxidase inhibitor (MAOI) with a tricyclic antidepressant (TCA) is considered to be contra-indicated because there is a risk that the recipient develops a serotonin syndrome. An accidental clinical observation motivated us to search and study publications relating to the risk an...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Tijdschrift voor psychiatrie 2016, Vol.58 (12), p.886-890
Hauptverfasser:	Schipper, P, Vanmolkot, L, Peeters, F P M L
Format:	Artikel
Sprache:	dut
Schlagworte:	Antidepressive Agents - therapeutic use Antidepressive Agents, Tricyclic - therapeutic use Depressive Disorder, Treatment-Resistant - drug therapy Drug Therapy, Combination Female Humans Middle Aged Monoamine Oxidase Inhibitors - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!